Skip to content

comparison of ease and duration of intubation with Macintosh versus King vision video-laryngoscope using COVID-19 barrier box on manikins, so that we can use one of them (according to study outcome showing ease of intubation) for intubation of COVID patients

Comparison of endotracheal intubation with Macintosh versus King vision video-laryngoscope using COVID-19 barrier box on manikins: A randomised crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031052
Enrollment
32
Registered
2021-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: COVID Barrier box: We intend to see ease and duration of intubation in Macintosh vs KVVL laryngoscope by using COVID barrier box on Manikin

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Faculty members and residents of Anaesthesia and Emergency medicine having intubation experience more than 1 year

Exclusion criteria

Exclusion criteria: Faculty members and residents of Anaesthesia and Emergency medicine having intubation experience more than 1 year not willing to take part in the study

Design outcomes

Primary

MeasureTime frame
Time required for successful intubation (IT) in seconds measured by an observerTimepoint: The outcome ( IT) in seconds will be assessed from base line i.e. 0 seconds to time required for successful intubation

Secondary

MeasureTime frame
Ease of Intubation ( Perception of intubation difficulties, no. of attempts of intubation)Timepoint: From base line i.e. 0 seconds, when intubation starts to completion of successful intubation

Countries

India

Contacts

Public ContactDr Satyabrata Guru

AIIMS, Bhubaneswar

satyabrataguru25@gmail.com9438641011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026